Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(17/week)
Canada
(12/week)
Haiti
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
View all
(29/week)
News
United States
(1301/week)
Manufacturing
(724/week)
Energy
(519/week)
Technology
(1265/week)
Other Manufacturing
(494/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
CDK inhibitor
Aug 13, 2020
PIQRAY® is approved and now available in Canada as the first and only treatment specifically for patients with a PIK3CA mutation in HR-positive, HER2-negative advanced breast cancer
Sep 29, 2019
Verzenio® (abemaciclib) Significantly Extends Life by a Median of 9.4 Months for Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2 Study
Sep 19, 2019
Addition of KISQALI® to drug plan in Quebec expands access to treatment for metastatic breast cancer
Aug 22, 2019
CStone completes registration filing for the Phase I trial of CDK4/6 inhibitor CS3002 in Australia and will soon initiate the study
May 20, 2019
Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology
Oct 19, 2018
Merrimack Discontinues Phase 2 SHERLOC Study of MM-121 in Patients with Non-Small Cell Lung Cancer Due to Futility
Jan 08, 2018
MEI Pharma Announces FDA Clearance of Investigational New Drug Application for CDK Inhibitor Voruciclib
Dec 21, 2017
MEI Pharma Announces Study of Clinical Stage Oral CDK Inhibitor Voruciclib Published in Nature Scientific Reports
Nov 27, 2017
World Cyclin-Dependent Kinase (CDK) Inhibitors Therapeutics Pipeline Analysis 2017 - Approximately 24 Drug Candidates in Different Stages of Development
Nov 16, 2017
Global Cancer CDK Inhibitors Market & Clinical Pipeline 2017-2022 - $20 Billion Market Opportunity Assessment
Nov 14, 2017
Cyclin-Dependent Kinase (CDK) Inhibitors Therapeutics - Pipeline Analysis 2017
Sep 05, 2017
MEI Pharma Announces Exclusive License Agreement with Presage Biosciences for Voruciclib, An Oral, Selective CDK Inhibitor
Latest News
Jul 27, 2024
LuxCreo Expands Partnership with ASICS to Make Personalized Shoes Accessible to Everyone
Jul 27, 2024
Smith Foundry Shutting Down Minnesota Facility
Jul 27, 2024
Fonon Corporation Quartz Laser Welding Benefits Glass Manufacturers
Jul 27, 2024
Pioneer Power Announces Filing of Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2023
Jul 27, 2024
Philippines says 'no incidents' as it resupplies hotspot reef
Jul 27, 2024
Alliance Resource Partners, L.P. Declares Quarterly Distribution of $0.70 Per Unit; Announces Robinson...
Jul 27, 2024
EnerSys Completes Acquisition Of Bren-Tronics To Expand Presence In Critical Defense Applications
Jul 27, 2024
Warrior Announces Regular Quarterly Cash Dividend
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
View All Events